Mr. Mark Jeffery Lavsky is a Cincinnati, Ohio based male podiatrist who is specialized in Podiatrist. Active license number of Mr. Mark Jeffery Lavsky is 03114864 in Ohio. Mr. Mark Jeffery Lavsky is qualified by a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Mr. Mark Jeffery Lavsky speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
RPH
Gender:
Male
Practice Address:
3200 Vine St, Cincinnati, Ohio, 45220-2213
Phone:
513-861-3100
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1649371899
NPI Enumeration Date:
26 Sep, 2006
NPI Last Update On:
20 Mar, 2013
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Mark Jeffery Lavsky are as mentioned below.
License Number
Specialization
State
Status
03114864
Ohio
Primary
36002590
Podiatry
Ohio
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4210 Fieldsedge Dr, Mason, Ohio
Zip:
45040-8539
Phone Number:
513-398-1812
Fax Number:
--
Patients can reach Mr. Mark Jeffery Lavsky at 3200 Vine St, Cincinnati, Ohio or can call to book an appointment on 513-861-3100. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.